Advertisement

Neogen Corporation NEOG

Set alert

Price alert · NEOG

All alert types
11.82 USD -0.44 -3.59%

At close · Oct 30

11.82 0.00 0.00%

After hours · Oct 30, 4:00 PM ET

Bid
11.81 × 2
Ask
11.82 × 2
11.63 Day range 12.24
5.41 52-week range 13.98
YTD
+69.10%
1 year
+97.00%
Open
12.15
Prev close
12.26
Mkt cap
2.58B
Vol
1.95M
Avg vol
3.35M
EPS
-0.26
P/E
0.00
Div yield
0.00%
More statistics
Low
11.63
High
12.24
Forward P/E
26.03
Beta
1.79
Short ratio
2.26
Inst. own
111.21%
Dividend
0.00
Ex-div date
Earnings
Jan 14, 2027
50-d avg
12.23
200-d avg
10.41
1y target
14.00

2Y chart

Chart tools
Interval

Events in this range
  • Oct 9, 2025Earnings: 0.04; estimate -0.074; surprise 154.05%
  • Dec 10, 2025Rating: CJS Securities · Market Perform → Market Outperform
  • Jan 8, 2026Earnings: 0.1; estimate 0.07; surprise 42.86%
  • Jan 9, 2026Rating: Guggenheim · Buy → Buy
  • Jan 12, 2026Rating: Piper Sandler · Neutral → Neutral
  • Apr 9, 2026Earnings: 0.09; estimate 0.04; surprise 125%
  • Jul 30, 2026Earnings: 0.09; estimate 0.05667; surprise 58.81%
  • Aug 3, 2026Rating: Piper Sandler · Neutral → Neutral
  • Aug 26, 2026Rating: Piper Sandler · Neutral → Overweight
  • Sep 30, 2026Rating: Guggenheim · Buy → Buy
  • Oct 6, 2026Earnings: 0.08; estimate 0.05333; surprise 50.01%
Signals (87)
NameDateAgo
SMA: BearishOct 30, 20262 days ago
SMA: BullishOct 29, 20263 days ago
SMA: BearishOct 28, 20264 days ago
MACD: Buy SignalOct 27, 20265 days ago
SMA: BearishOct 16, 20262 weeks ago
SMA: BearishOct 6, 20263 weeks ago
MACD: Sell SignalSep 30, 20261 month ago
RSI: OverboughtSep 17, 20261 month ago
MACD: Buy SignalSep 16, 20261 month ago
MACD: Sell SignalAug 21, 20262 months ago
MACD: Buy SignalJul 30, 20263 months ago
RSI: OverboughtJul 30, 20263 months ago
SMA: BullishJul 29, 20263 months ago
SMA: BearishJul 28, 20263 months ago
MACD: Sell SignalJul 23, 20263 months ago
SMA: BullishJul 1, 20264 months ago
SMA: BearishJun 30, 20264 months ago
MACD: Buy SignalJun 25, 20264 months ago
SMA: BullishJun 24, 20264 months ago
MACD: Sell SignalJun 23, 20264 months ago
SMA: BearishJun 22, 20264 months ago
SMA: BullishJun 18, 20264 months ago
SMA: BearishJun 17, 20264 months ago
SMA: BullishJun 15, 20264 months ago
SMA: BearishJun 12, 20264 months ago
SMA: BullishJun 11, 20264 months ago
SMA: BearishJun 10, 20264 months ago
SMA: BullishJun 9, 20264 months ago
SMA: BearishMay 29, 20265 months ago
SMA: BullishMay 27, 20265 months ago
MACD: Buy SignalMay 22, 20265 months ago
MACD: Sell SignalMay 4, 20266 months ago
MACD: Buy SignalMay 1, 20266 months ago
MACD: Sell SignalApr 29, 20266 months ago
SMA: BearishApr 9, 20266 months ago
SMA: BullishApr 8, 20266 months ago
MACD: Buy SignalMar 31, 20267 months ago
RSI: OversoldMar 18, 20267 months ago
RSI: OversoldMar 13, 20267 months ago
SMA: BearishMar 6, 20268 months ago
RSI: OverboughtFeb 24, 20268 months ago
MACD: Sell SignalFeb 2, 20269 months ago
MACD: Buy SignalJan 8, 20269 months ago
RSI: OverboughtJan 8, 20269 months ago
MACD: Sell SignalDec 31, 202510 months ago
RSI: OverboughtDec 18, 202510 months ago
RSI: OverboughtDec 10, 202510 months ago
SMA: BullishDec 9, 202510 months ago
SMA: BullishDec 8, 202510 months ago
MACD: Buy SignalDec 8, 202510 months ago
SMA: BullishNov 25, 202511 months ago
SMA: BearishNov 18, 202511 months ago
MACD: Sell SignalNov 18, 202511 months ago
MACD: Buy SignalNov 10, 202511 months ago
MACD: Sell SignalNov 4, 202512 months ago
MACD: Buy SignalNov 3, 202512 months ago
MACD: Sell SignalOct 30, 20251 year ago
MACD: Buy SignalOct 24, 20251 year ago
MACD: Sell SignalOct 17, 20251 year ago
RSI: OverboughtOct 9, 20251 year ago
MACD: Buy SignalOct 1, 20251 year ago
SMA: BullishSep 17, 20251 year ago
SMA: BearishSep 16, 20251 year ago
MACD: Sell SignalSep 8, 20251 year ago
SMA: BullishAug 12, 20251 year ago
MACD: Buy SignalAug 7, 20251 year ago
MACD: Sell SignalJul 31, 20251 year ago
MACD: Buy SignalJul 23, 20251 year ago
MACD: Sell SignalJul 18, 20251 year ago
MACD: Buy SignalJul 2, 20251 year ago
MACD: Sell SignalJun 17, 20251 year ago
MACD: Buy SignalJun 16, 20251 year ago
MACD: Sell SignalJun 2, 20251 year ago
MACD: Buy SignalApr 25, 20251 year ago
RSI: OversoldApr 8, 20251 year ago
RSI: OversoldApr 4, 20251 year ago
MACD: Sell SignalApr 3, 20251 year ago
MACD: Buy SignalApr 2, 20251 year ago
RSI: OversoldMar 25, 20251 year ago
MACD: Sell SignalMar 14, 20251 year ago
RSI: OversoldMar 3, 20251 year ago
MACD: Buy SignalFeb 20, 20251 year ago
RSI: OversoldFeb 11, 20251 year ago
MACD: Sell SignalFeb 3, 20251 year ago
MACD: Buy SignalJan 22, 20251 year ago
MACD: Sell SignalJan 17, 20251 year ago
MACD: Buy SignalDec 24, 20241 year ago

Key statistics

Market cap
2.56B
Enterprise value
3.28B
Trailing P/E
0.00
Forward P/E
26.03
PEG ratio
0.66
Price / sales
2.89
Price / book
1.23
EPS (TTM)
-0.26
Beta
1.79
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-6.35%
Revenue (TTM)
884.00M
Revenue growth
6.50%
Free cash flow
38.94M
Total cash
172.00M
Total debt
774.30M
Return on equity
-2.67%
Shares outstanding
218.31M
Short % of float
7.30%
50-day average
12.23
200-day average
10.41

Analyst view

Consensus: buy

Buy
Price target (mean) 14.00
Ratings (0m) 4 3 buy · 1 hold · 0 sell
  • Strong buy2
  • Buy1
  • Hold1
  • Sell0
  • Strong sell0

Next earnings

Jan 14, 2027

Expected Jan 14, 2027. Consensus EPS estimate 0.06333.

Earnings history

Financials — quick view

All financials
NEOG Revenue — quarterly 222.80M
2023-Q2 20222023-Q3 20232023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 20242024-Q4 20242025-Q1 20242025-Q2 20242025-Q3 20252025-Q4 20252026-Q1 20252026-Q2 20252026-Q3 20262026-Q4 20262027-Q1 2026
NEOG Net income — quarterly -11.90M
2023-Q2 20222023-Q3 20232023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 20242024-Q4 20242025-Q1 20242025-Q2 20242025-Q3 20252025-Q4 20252026-Q1 20252026-Q2 20252026-Q3 20262026-Q4 20262027-Q1 2026
NEOG EPS — quarterly -0.05
2023-Q2 20222023-Q3 20232023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 20242024-Q4 20242025-Q1 20242025-Q2 20242025-Q3 20252025-Q4 20252026-Q1 20252026-Q2 20252026-Q3 20262026-Q4 20262027-Q1 2026

Earnings

NEOG recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Jan 14, 2027Nov 30, 20260.07———
Oct 6, 2026Aug 31, 20260.053330.08+0.03+50.01%
Jul 30, 2026May 31, 20260.056670.09+0.03+58.81%
Apr 9, 2026Feb 28, 20260.040.09+0.05+125.00%
Jan 8, 2026Nov 30, 20250.070.10+0.03+42.86%
Oct 9, 2025Aug 31, 2025-0.0740.04+0.11+154.05%

Upgrades / downgrades

NEOG analyst upgrades and downgrades
DateFirmActionFromTo
Sep 30, 2026GuggenheimmainBuyBuy
Aug 26, 2026Piper SandlerupNeutralOverweight
Aug 3, 2026Piper SandlerreitNeutralNeutral
Jan 12, 2026Piper SandlerreitNeutralNeutral
Jan 9, 2026GuggenheimmainBuyBuy
Dec 10, 2025CJS SecuritiesupMarket PerformMarket Outperform

About Neogen Corporation

Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through Food Safety and Animal Safety segments. The company offers diagnostic test kits and complementary products to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns. It also provides reagents and test kits used in immunoassay production, forensic and animal toxicology, and life science research; unique colorimetric and chemiluminescent substrates for research use; veterinary instruments and delivery systems under the Ideal and Prima Tech brands; and precision instruments designed for injections, topical and oral administration, artificial insemination, and animal identification for farmers, ranchers, and veterinarian under the Prima Tech brand. In addition, the company offers digestive aids and nutritional supplements; Natural Vitamin E-AD to address vitamin deficiencies in swine, cattle, and sheep; RenaKare; companion animal parasiticides under Provecta brand; BotVax B; EqStim; ImmunoRegulin; companion animal parasiticides under the Provecta brand; rodent and insect control products under the Ramik, CyKill, Havoc, Prozap, SureKill, and StandGuard brands. Further, it markets Uniprim, a veterinary antibiotic; operates sgenomics labs offering DNA genotyping, sequencing, and trait analysis for livestock and companion animals; and provides software systems that help testers to analyze and store results and perform analysis. The company has a strategic collaboration with Hinalea Imaging Corp. to develop digital imaging solutions for food safety and quality inspection. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.

Sector
Healthcare
Industry
Medical Devices
Country
United States
Website
neogen.com

News

Your note

Sign in to keep a note on NEOG — it syncs with the Stock Master app.

Insider holders

NEOG insider holders
InsiderRelationLatest transactionDateShares held
ADENT JOHN EDWARDFormerConversion of Exercise of derivative securityOct 26, 2025363,081
BOEHM WILLIAM TDirectorConversion of Exercise of derivative securityOct 26, 202547,913
BOREL JAMES C.DirectorConversion of Exercise of derivative securityOct 26, 202594,570
JONES DOUGLAS EDWARDFormerConversion of Exercise of derivative securityOct 26, 2025100,881
NAEMURA DAVID HARTMANFormerConversion of Exercise of derivative securityNov 30, 202590,388
NASSIF MIKHEALChief Executive OfficerStock Award(Grant)Aug 13, 2026141,631

Institution ownership

NEOG institution ownership
Holder% heldSharesValueReported
Blackrock Inc.15.31%33,431,015391.64MJun 29, 2026
Neuberger Berman Group, LLC7.59%16,570,795194.13MJun 29, 2026
Vanguard Portfolio Management LLC5.97%13,038,732152.75MJun 29, 2026
Dimensional Fund Advisors LP4.50%9,828,174115.14MJun 29, 2026
Vanguard Capital Management LLC4.42%9,655,248113.11MJun 29, 2026
SG Americas Securities, LLC4.28%9,352,065109.56MJun 29, 2026

Fund ownership

NEOG fund ownership
Holder% heldSharesValueReported
iShares Trust-iShares Core S&P Small-Cap ETF5.95%12,983,088152.10MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.17%6,928,35881.17MJun 29, 2026
NEUBERGER BERMAN EQUITY FUNDS-Neuberger Genesis Fund3.13%6,842,46480.16MSep 29, 2026
iShares Trust-iShares Russell 2000 ETF2.63%5,738,52667.23MSep 29, 2026
BARON INVESTMENT Fd.S TRT -Baron Small Cap Fd.2.29%5,000,00058.58MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund2.28%4,987,15858.42MJun 29, 2026
Advertisement